IVERIC bio Inc (ISEE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5 PENN PLAZA NEW YORK, NY 10001

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.

Data as of 2021-07-25 17:03:56 -0400
Market Cap808.962 Million Shares Outstanding90.387 Million Avg 30-day Volume3.674 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.1 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.20323 52-week High/Low10.25 / 3.97 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from ISEE instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 6 -50.0% 3 (0.18%) 5 (0.29%) -40.0%
Funds Holding: 116 121 -4.13% 42 (2.46%) 47 (2.73%) -10.64%
13F shares: 80.196 Million 80.843 Million -0.8% 56.058 Million 56.929 Million -1.53%
% Ownership 88.9671 90.2592 -1.43% 62.1893 63.5597 -2.16%
New Positions: 11 37 -70.27% 3 12 -75.0%
Increased Positions 45 38 18.42% 17 14 21.43%
Closed Positions 16 18 -11.11% 8 8 0.0%
Reduced Positions 29 28 3.57% 13 15 -13.33%
Total Calls 800.963 Thousand 1.086 Million -26.26% 49.3 Thousand 381.3 Thousand -87.07%
Total Puts 367.317 Thousand 198.542 Thousand 85.01% 248.1 Thousand 77.1 Thousand 221.79%
PUT/CALL Ratio 0.46 0.18 155.56% 5.03 0.2 2415.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ISEE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ISEE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLUMENKRANZ MARK S.

  • Director
15,000 2021-07-15 2

BOLTE AXEL

  • Director
23,000 2021-05-19 1

HENDERSON JANE

  • Director
23,000 2021-05-19 1

GRAVES ADRIENNE L

  • Director
23,000 2021-05-19 1

ROBERTS CALVIN W.

  • Director
23,000 2021-05-19 1

DUGEL PRAVIN PRESIDENT

  • Officer
52,250 2021-05-03 3

WESTBY KEITH SVP & COO

  • Officer
86,466 2020-12-31 4

CARROLL DAVID FRANCIS SVP, CFO AND TREASURER

  • Officer
80,165 2020-12-31 4

GUYER DAVID R EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2020-12-18 3

SBLENDORIO GLENN PRESIDENT & CEO

  • Officer
  • Director
0 2020-12-18 3

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
No longer subject to file 2020-06-19 0

REDLICK DAVID E

  • Director
0 2019-05-15 0

ROSS MICHAEL JAY

  • Director
0 2018-05-23 0

WOOD BARBARA A SVP, GEN. COUNSEL, SECRETARY

  • Officer
16,462 2018-01-04 0

PATEL SAMIR CHANDRAKANT PRESIDENT

  • Officer
  • Director
15,813 2017-01-04 0

BJARKE HENRIC BJORN SVP & CCO

  • Officer
1,684 2017-01-04 0

NOVO A/S

  • 10% Owner
No longer subject to file 2016-12-14 0

SMITH IAN F

  • Director
0 2016-08-02 0

GALAKATOS NICHOLAS

  • Director
9,629 2016-01-11 0

ATIEH MICHAEL G EVP, CFO, & CBO, TREASURER

  • Officer
295 2016-01-02 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • Director
  • 10% Owner
No longer subject to file 2015-05-26 0

SMITH TODD N SVP & CCO

  • Officer
0 2015-01-02 0

PEACOCK BRUCE CFO & CBO

  • Officer
0 2014-09-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BLUMENKRANZ MARK S. - Director

2021-07-19 16:13:56 -0400 2021-07-15 M 5,000 a 5,000 direct 1.3598 -6.59 1.3598 2 -7.2176 5

BLUMENKRANZ MARK S. - Director

2021-07-19 16:13:56 -0400 2021-07-15 M 5,000 d 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IVERIC BIO INC ISEE 2021-08-02 19:45:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 19:15:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 18:45:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 18:15:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 17:45:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 17:15:03 UTC -0.1966 0.2566 1300000
IVERIC BIO INC ISEE 2021-08-02 16:45:03 UTC -0.2692 0.3492 1300000
IVERIC BIO INC ISEE 2021-08-02 16:15:03 UTC -0.2692 0.3492 1300000
IVERIC BIO INC ISEE 2021-08-02 15:45:03 UTC -0.2692 0.3492 1300000
IVERIC BIO INC ISEE 2021-08-02 15:15:03 UTC -0.2692 0.3492 1300000
IVERIC BIO INC ISEE 2021-08-02 14:45:03 UTC -0.2668 0.3468 1300000
IVERIC BIO INC ISEE 2021-08-02 14:15:03 UTC -0.2668 0.3468 1300000
IVERIC BIO INC ISEE 2021-08-02 13:45:03 UTC -0.2668 0.3468 1300000
IVERIC BIO INC ISEE 2021-08-02 13:15:04 UTC -0.2668 0.3468 1300000
IVERIC BIO INC ISEE 2021-08-02 12:45:03 UTC -0.2668 0.3468 1300000
IVERIC BIO INC ISEE 2021-07-30 22:15:02 UTC -0.2668 0.3468 1200000
IVERIC BIO INC ISEE 2021-07-30 21:45:03 UTC -0.2668 0.3468 1200000
IVERIC BIO INC ISEE 2021-07-30 21:15:03 UTC -0.2668 0.3468 1200000
IVERIC BIO INC ISEE 2021-07-30 20:45:02 UTC -0.3065 0.3865 1200000
IVERIC BIO INC ISEE 2021-07-30 20:15:02 UTC -0.3065 0.3865 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments